CLEVELAND-CLIFFS INC (1CVA.MI) Fundamental Analysis & Valuation

BIT:1CVA • US1858991011

Current stock price

12.3 EUR
+4.81 (+64.18%)
Last:

This 1CVA.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1CVA.MI Profitability Analysis

1.1 Basic Checks

  • 1CVA had negative earnings in the past year.
  • 1CVA had a negative operating cash flow in the past year.
  • In multiple years 1CVA reported negative net income over the last 5 years.
  • 1CVA had a positive operating cash flow in 4 of the past 5 years.
1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCF1CVA.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

  • 1CVA has a worse Return On Assets (-8.26%) than 80.95% of its industry peers.
  • With a Return On Equity value of -30.66%, 1CVA is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.26%
ROE -30.66%
ROIC N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
1CVA.MI Yearly ROA, ROE, ROIC1CVA.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for 1CVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1CVA.MI Yearly Profit, Operating, Gross Margins1CVA.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. 1CVA.MI Health Analysis

2.1 Basic Checks

  • 1CVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for 1CVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1CVA.MI Yearly Shares Outstanding1CVA.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1CVA.MI Yearly Total Debt VS Total Assets1CVA.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • Based on the Altman-Z score of 1.18, we must say that 1CVA is in the distress zone and has some risk of bankruptcy.
  • 1CVA has a Altman-Z score of 1.18. This is in the lower half of the industry: 1CVA underperforms 71.43% of its industry peers.
  • 1CVA has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.47, 1CVA is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF N/A
Altman-Z 1.18
ROIC/WACCN/A
WACC9.96%
1CVA.MI Yearly LT Debt VS Equity VS FCF1CVA.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • 1CVA has a Current Ratio of 2.04. This indicates that 1CVA is financially healthy and has no problem in meeting its short term obligations.
  • 1CVA's Current ratio of 2.04 is fine compared to the rest of the industry. 1CVA outperforms 61.90% of its industry peers.
  • 1CVA has a Quick Ratio of 2.04. This is a bad value and indicates that 1CVA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1CVA has a worse Quick ratio (0.61) than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 0.61
1CVA.MI Yearly Current Assets VS Current Liabilites1CVA.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. 1CVA.MI Growth Analysis

3.1 Past

  • 1CVA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.75%.
EPS 1Y (TTM)-131.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.28%

3.2 Future

  • Based on estimates for the next years, 1CVA will show a very strong growth in Earnings Per Share. The EPS will grow by 46.87% on average per year.
  • Based on estimates for the next years, 1CVA will show a small growth in Revenue. The Revenue will grow by 2.40% on average per year.
EPS Next Y100.7%
EPS Next 2Y46.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.98%
Revenue Next 2Y5.55%
Revenue Next 3Y3.91%
Revenue Next 5Y2.4%

3.3 Evolution

1CVA.MI Yearly Revenue VS Estimates1CVA.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B
1CVA.MI Yearly EPS VS Estimates1CVA.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1CVA.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1CVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 715.85 indicates a quite expensive valuation of 1CVA.
  • 1CVA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1CVA is more expensive than 73.81% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1CVA to the average of the S&P500 Index (22.79), we can say 1CVA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 715.85
1CVA.MI Price Earnings VS Forward Price Earnings1CVA.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1CVA.MI Per share data1CVA.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1CVA does not grow enough to justify the current Price/Earnings ratio.
  • 1CVA's earnings are expected to grow with 46.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.87%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1CVA.MI Dividend Analysis

5.1 Amount

  • No dividends for 1CVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1CVA.MI Fundamentals: All Metrics, Ratios and Statistics

CLEVELAND-CLIFFS INC

BIT:1CVA (2/4/2026, 7:00:00 PM)

12.3

+4.81 (+64.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-09
Earnings (Next)05-05
Inst Owners69.37%
Inst Owner ChangeN/A
Ins Owners1.42%
Ins Owner ChangeN/A
Market Cap7.01B
Revenue(TTM)N/A
Net Income(TTM)-1.68B
Analysts66.32
Price Target11.03 (-10.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-17.56%
Min EPS beat(2)-29.71%
Max EPS beat(2)-5.42%
EPS beat(4)0
Avg EPS beat(4)-28.19%
Min EPS beat(4)-49.04%
Max EPS beat(4)-5.42%
EPS beat(8)2
Avg EPS beat(8)-12.74%
EPS beat(12)4
Avg EPS beat(12)-6.52%
EPS beat(16)5
Avg EPS beat(16)-9.76%
Revenue beat(2)0
Avg Revenue beat(2)-2.61%
Min Revenue beat(2)-4.34%
Max Revenue beat(2)-0.88%
Revenue beat(4)0
Avg Revenue beat(4)-2.42%
Min Revenue beat(4)-4.34%
Max Revenue beat(4)-0.88%
Revenue beat(8)0
Avg Revenue beat(8)-2.88%
Revenue beat(12)2
Avg Revenue beat(12)-2.04%
Revenue beat(16)4
Avg Revenue beat(16)-1.58%
PT rev (1m)36.36%
PT rev (3m)36.36%
EPS NQ rev (1m)-230.03%
EPS NQ rev (3m)-230.03%
EPS NY rev (1m)-42.31%
EPS NY rev (3m)-42.31%
Revenue NQ rev (1m)-5.74%
Revenue NQ rev (3m)-5.74%
Revenue NY rev (1m)-2.93%
Revenue NY rev (3m)-2.93%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 715.85
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 3.29
EV/EBITDA N/A
EPS(TTM)-2.46
EYN/A
EPS(NY)0.02
Fwd EY0.14%
FCF(TTM)-2.29
FCFYN/A
OCF(TTM)-1.36
OCFYN/A
SpS27.56
BVpS8.09
TBVpS3.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.26%
ROE -30.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.93%
ROA(5y)4.16%
ROE(3y)3.63%
ROE(5y)12.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 1.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.27%
Cap/Sales 3.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 0.61
Altman-Z 1.18
F-Score2
WACC9.96%
ROIC/WACCN/A
Cap/Depr(3y)76.89%
Cap/Depr(5y)95.94%
Cap/Sales(3y)3.55%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-131.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.17%
EPS Next Y100.7%
EPS Next 2Y46.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.28%
Revenue Next Year7.98%
Revenue Next 2Y5.55%
Revenue Next 3Y3.91%
Revenue Next 5Y2.4%
EBIT growth 1Y-2565.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year115.03%
EBIT Next 3Y78.15%
EBIT Next 5Y47.39%
FCF growth 1Y-210.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-143.77%
OCF growth 3Y-66.47%
OCF growth 5Y-28.65%

CLEVELAND-CLIFFS INC / 1CVA.MI Fundamental Analysis FAQ

What is the fundamental rating for 1CVA stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1CVA.MI.


Can you provide the valuation status for CLEVELAND-CLIFFS INC?

ChartMill assigns a valuation rating of 1 / 10 to CLEVELAND-CLIFFS INC (1CVA.MI). This can be considered as Overvalued.


What is the profitability of 1CVA stock?

CLEVELAND-CLIFFS INC (1CVA.MI) has a profitability rating of 1 / 10.


What is the financial health of CLEVELAND-CLIFFS INC (1CVA.MI) stock?

The financial health rating of CLEVELAND-CLIFFS INC (1CVA.MI) is 2 / 10.


What is the earnings growth outlook for CLEVELAND-CLIFFS INC?

The Earnings per Share (EPS) of CLEVELAND-CLIFFS INC (1CVA.MI) is expected to grow by 100.7% in the next year.